LOL. I've seen "FDA doesn't approve on anecdotal evidence" about both HGEN and CYDY. Which is why we have the bureaucratic FDA who only caters to big pharma trying to slow down both CYDY and HGEN by requiring these lengthy but necessary clinical trials. Gilead didn't have to wait months to push their COVID drug!
Pourhassan said on a recent conference call that he expects CYDY stock to be in the three figure range once he get's the FDA approvals. Now that's a buyout deal I'd like to be part of!
Durrant really don't say much at all about anything - very frustrating.
News 
Market Data 
Discover 
AI
